Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
27,04 USD | +1,65% | +10,28% | -16,75% |
02/05 | CORCEPT THERAPEUTICS INCORPORATED : Truist Securities toujours à l'achat | ZM |
01/05 | Transcript : Corcept Therapeutics Incorporated, Q1 2024 Earnings Call, May 01, 2024 |
Métier
Nombre d'employés: 352
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 402 | 100,0 % | 482 | 100,0 % | +20,04% |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 402 | 100,0 % | 482 | 100,0 % | +20,04% |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Joseph Belanoff
FOU | Founder | 66 | 13/05/98 |
Atabak Mokari
DFI | Director of Finance/CFO | 47 | 01/03/21 |
Joseph Lyon
CTO | Chief Tech/Sci/R&D Officer | 46 | 01/06/12 |
Hazel Hunt
CTO | Chief Tech/Sci/R&D Officer | 64 | 01/01/11 |
Jerry Pan
IRC | Investor Relations Contact | - | 01/10/21 |
Amy E. Flood
IRO | Public Communications Contact | - | 12/07/21 |
William Guyer
PRN | Corporate Officer/Principal | 56 | 16/08/21 |
Monica Tellado
PRN | Corporate Officer/Principal | 51 | 01/11 |
Sean Maduck
PRN | Corporate Officer/Principal | 47 | 01/01/12 |
Gary Robb
SEC | Corporate Secretary | 61 | 01/09/11 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Joseph Belanoff
FOU | Founder | 66 | 13/05/98 |
Gregg Alton
BRD | Director/Board Member | 58 | 12/03/20 |
George Baker
BRD | Director/Board Member | 81 | 01/01/99 |
James Wilson
CHM | Chairman | 80 | 01/01/99 |
David Mahoney
BRD | Director/Board Member | 69 | 01/07/04 |
Daniel Swisher
BRD | Director/Board Member | 61 | 18/06/15 |
Kimberly Park
BRD | Director/Board Member | 60 | 18/09/19 |
Gillian Cannon
BRD | Director/Board Member | 60 | 23/11/20 |
Joshua Murray
BRD | Director/Board Member | 40 | 09/06/21 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 135 312 088 | 92 262 472 ( 68,18 %) | 31 200 000 ( 23,06 %) | 68,18 % |
Coordonnées société
Corcept Therapeutics, Inc.
149 Commonwealth Drive
94025, Menlo Park
+650 327 3270
http://www.corcept.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-16,75% | 2,82 Md | |
+30,38% | 684 Md | |
+26,51% | 568 Md | |
-4,36% | 361 Md | |
+19,30% | 329 Md | |
+3,73% | 284 Md | |
+16,70% | 240 Md | |
+8,78% | 208 Md | |
-7,93% | 200 Md | |
+7,68% | 166 Md |
- Bourse
- Actions
- Action CORT
- Société Corcept Therapeutics Incorporated